|
1
|
Shimada K, Kinoshita T, Naoe T and
Nakamura S: Presentation and management of intravascular large
B-cell lymphoma. Lancet Oncol. 10:895–902. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pfleger L and Tappeiner J: On the
recognition of systematized endotheliomatosis of the cutaneous
blood vessels (reticuloendotheliosis? Hautarzt. 10:359–363.
1959.(In German). PubMed/NCBI
|
|
3
|
Sanguedolce F, Zanelli M, Zizzo M, Bisagni
A, Soriano A, Cocco G, Palicelli A, Santandrea G, Caprera C, Corsi
M, et al: Primary pulmonary B-Cell lymphoma: A review and update.
Cancers (Basel). 13:4152021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brunet V, Marouan S, Routy JP, Hashem MA,
Bernier V, Simard R, Petrella T, Lamarre L, Théorêt G, Carrier C,
et al: Retrospective study of intravascular large B-cell lymphoma
cases diagnosed in Quebec: A retrospective study of 29 case
reports. Medicine (Baltimore). 96:e59852017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Satoh T, Arai E, Kayano H, Sakaguchi H,
Takahashi N, Tsukasaki K and Yasuda M: Pulmonary intravascular
large B-cell lymphoma accompanying synchronous primary pulmonary
adenocarcinoma and benign interstitial lesions. J Clin Exp Hematop.
59:140–144. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Masood S, Vijayan K and Wheeler YY:
Primary lung intravascular large B-cell lymphoma clinically
mimicking sarcoidosis: A rare case report and review of literature.
Respir Med Case Rep. 29:1009892019.PubMed/NCBI
|
|
7
|
Geer M, Roberts E, Shango M, Till BG,
Smith SD, Abbas H, Hill BT, Kaplan J, Barr PM, Caimi P, et al:
Multicentre retrospective study of intravascular large B-cell
lymphoma treated at academic institutions within the United States.
Br J Haematol. 186:255–262. 2019.PubMed/NCBI
|
|
8
|
Swerdlow SH, Campo E, Pileri SA, Harris
NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz
AD and Jaffe ES: The 2016 revision of the World Health Organization
classification of lymphoid neoplasms. Blood. 127:2375–2390. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Orwat DE and Batalis NI: Intravascular
large B-cell lymphoma. Arch Pathol Lab Med. 136:333–338. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ponzoni M, Campo E and Nakamura S:
Intravascular large B-cell lymphoma: A chameleon with multiple
faces and many masks. Blood. 132:1561–1567. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu F, Wang Z, Xing X, Yu M and Shi B: The
value of 18F-FDG PET/CT in diagnostic procedure of
intravascular large B-cell lymphoma presenting fever of unknown
origin and pulmonary hypertension as an initial manifestation. Clin
Nucl Med. 41:506–507. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang H, Huang Y, Xu CW and Lin L: Clinical
analysis of tumor and non-tumor patients complicated with pulmonary
embolism. Int J Clin Exp Med. 8:18729–18736. 2015.PubMed/NCBI
|
|
13
|
Matea F, Alowami S, Bonert M, Sur M,
Shargall Y and Naqvi AH: Pulmonary intravascular B-cell lymphoma
with angiotropism/angioinvasion mimicking interstitial lung
disease: A clinical dilemma and potential diagnostic challenge.
Case Rep Hematol. 2018:38213922018.PubMed/NCBI
|
|
14
|
Nguyen TT, Sekiguchi H, Yi ES and Ryu JH:
Occult diffuse neoplasm in the lungs: Intravascular large B-cell
lymphoma. Am J Med. 134:926–929. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Spencer J, Dusing R, Yap W, Hill J and
Walter C: Intravascular large B-cell lymphoma presenting with
diffusely increased pulmonary fluorodeoxyglucose uptake without
corresponding CT abnormality. Radiol Case Rep. 14:260–264. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hong JY, Kim HJ, Ko YH, Choi JY, Jung CW,
Kim SJ and Kim WS: Clinical features and treatment outcomes of
intravascular large B-cell lymphoma: A single-center experience in
Korea. Acta Haematol. 131:18–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sullivan HC, Edgar MA, Cohen C, Kovach CK,
HooKim K and Reid MD: The utility of ERG, CD31 and CD34 in the
cytological diagnosis of angiosarcoma: An analysis of 25 cases. J
Clin Pathol. 68:44–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Robetorye RS, Ramsower CA, Rosenthal AC,
Yip TK, Wendel Spiczka AJ, Glinsmann-Gibson BJ and Rimsza LM:
Incorporation of digital gene expression profiling for
cell-of-origin determination (Lymph2Cx testing) into the routine
work-up of diffuse large B-cell lymphoma. J Hematop. 2:3–10. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scott DW, Mottok A, Ennishi D, Wright GW,
Farinha P, Ben-Neriah S, Kridel R, Barry GS, Hother C, Abrisqueta
P, et al: Prognostic significance of diffuse large B-cell lymphoma
cell of origin determined by digital gene expression in
formalin-fixed paraffin-embedded tissue biopsies. J Clin Oncol.
33:2848–2856. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He X, Chen Z, Fu T, Jin X, Yu T, Liang Y,
Zhao X and Huang L: Ki-67 is a valuable prognostic predictor of
lymphoma but its utility varies in lymphoma subtypes: Evidence from
a systematic meta-analysis. BMC Cancer. 14:1532014. View Article : Google Scholar : PubMed/NCBI
|
